NEW YORK (GenomeWeb News) – The Massachusetts General Hospital Cancer Center plans to begin using gene-based tests for nearly all of its cancer patients to help make treatment decisions as part of a personalized healthcare initiative, it said this week.

The hospital said it will use its newly opened translational research laboratory to support this program, which also is aimed at gathering research data from tumors that may contribute to more personalized treatments in the future.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.